An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
There is a clinical need for new, more effective treatments for chronic and debilitating inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. Targeting drugs selectively to the inflamed intestine may improve therapeutic outcomes and minimize systemic toxicity. We repor...
Main Authors: | , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
American Association for the Advancement of Science (AAAS)
2017
|
Online Access: | http://hdl.handle.net/1721.1/109405 https://orcid.org/0000-0002-9481-2258 https://orcid.org/0000-0002-4260-2785 https://orcid.org/0000-0003-4255-0492 |